Cargando…
Recent developments in using mechanistic cardiac modelling for drug safety evaluation
On the tenth anniversary of two key International Conference on Harmonisation (ICH) guidelines relating to cardiac proarrhythmic safety, an initiative aims to consider the implementation of a new paradigm that combines in vitro and in silico technologies to improve risk assessment. The Comprehensive...
Autores principales: | Davies, Mark R., Wang, Ken, Mirams, Gary R., Caruso, Antonello, Noble, Denis, Walz, Antje, Lavé, Thierry, Schuler, Franz, Singer, Thomas, Polonchuk, Liudmila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909717/ https://www.ncbi.nlm.nih.gov/pubmed/26891981 http://dx.doi.org/10.1016/j.drudis.2016.02.003 |
Ejemplares similares
-
Use of Patient Health Records to Quantify Drug-Related Pro-arrhythmic Risk
por: Davies, Mark R., et al.
Publicado: (2020) -
Models of the cardiac L‐type calcium current: A quantitative review
por: Agrawal, Aditi, et al.
Publicado: (2022) -
Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing
por: Mirams, Gary R, et al.
Publicado: (2012) -
Rapid Characterization of hERG Channel Kinetics I: Using an Automated High-Throughput System
por: Lei, Chon Lok, et al.
Publicado: (2019) -
PKPD modeling of acquired resistance to anti-cancer drug treatment
por: Eigenmann, Miro J., et al.
Publicado: (2017)